Logo.jpg
INVECTYS, MD ANDERSON AND CTMC ANNOUNCE STRATEGIC COLLABORATION FOR CAR T CELL THERAPY DEVELOPMENT
June 16, 2022 09:00 ET | Invectys, Inc.
HOUSTON, June 16, 2022 (GLOBE NEWSWIRE) -- Invectys, Inc. (Invectys), The University of Texas MD Anderson Cancer Center and the Cell Therapy Manufacturing Center (CTMC), a joint venture between...
Logo.jpg
Invectys appoints Timothy Papp as its Chief Financial Officer
May 12, 2022 10:00 ET | Invectys, Inc.
Houston, Texas, USA, May 12, 2022 (GLOBE NEWSWIRE) -- Invectys, Inc. of Houston, Texas, a clinical stage immunotherapy company dedicated to the development of a next generation of therapies to meet...
Logo.jpg
Invectys, Inc. Appoints François Lescure as General Manager of its R&D Subsidiary, Invectys, SAS 
April 11, 2022 10:00 ET | Invectys, Inc.
Houston, Texas, USA, April 11, 2022 (GLOBE NEWSWIRE) -- Invectys, Inc. of Houston, Texas, a clinical stage immunotherapy company which is developing a next generation of therapies to meet the needs...
Logo.jpg
Wayne A. Marasco, M.D., Ph.D. joins Invectys’ Scientific Advisory Board
March 09, 2022 10:00 ET | Invectys, Inc.
Houston, Texas, USA, March 09, 2022 (GLOBE NEWSWIRE) -- Invectys, Inc. of Houston, Texas, a clinical stage immunotherapy company dedicated to the development of a next generation of therapies to...
Logo.jpg
Invectys appoints Jian Cao, Ph.D., as Vice President, Pharmaceutical Development
March 01, 2022 09:15 ET | Invectys, Inc.
Houston, Texas, USA, March 01, 2022 (GLOBE NEWSWIRE) -- Invectys, Inc. of Houston, Texas, a clinical stage immunotherapy company dedicated to the development of a next generation of therapies to...
Logo.jpg
Invectys, Inc appoints Biopharma Veteran, Praveen Tyle, PhD as President & CEO
May 04, 2021 11:00 ET | Invectys, Inc.
Houston, TX, USA, May 04, 2021 (GLOBE NEWSWIRE) -- Invectys, Inc., a clinical-stage immunotherapy company headquartered in Houston and dedicated to the development of a new generation of products...